"use strict";(self.webpackChunkBenStockTracker=self.webpackChunkBenStockTracker||[]).push([[5676],{5676:e=>{e.exports=JSON.parse('{"4e3782f3-1528-3eb7-aefb-0b8f5fb02aa5":{"uuid":"4e3782f3-1528-3eb7-aefb-0b8f5fb02aa5","title":"Gilead\'s Social Justice Experience Helps Raise Awareness of the Black Journey in the United States","publisher":"News Direct","link":"https://finance.yahoo.com/news/gileads-social-justice-experience-helps-124530866.html","providerPublishTime":1656074730,"type":"STORY","thumbnail":{"resolutions":[{"url":"https://s.yimg.com/uu/api/res/1.2/71eHINzWOf3a6btNvkWS5w--~B/aD0zNjY7dz02NTA7YXBwaWQ9eXRhY2h5b24-/https://s.yimg.com/uu/api/res/1.2/iY_oP8B61u18.SbjpkK9CA--~B/aD0zNjY7dz02NTA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/news_direct/db8baa3ed220ee1c2ffecf13ab7d4a9e","width":650,"height":366,"tag":"original"},{"url":"https://s.yimg.com/uu/api/res/1.2/zSlHphqwIyoHBqIlhC3byg--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://s.yimg.com/uu/api/res/1.2/iY_oP8B61u18.SbjpkK9CA--~B/aD0zNjY7dz02NTA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/news_direct/db8baa3ed220ee1c2ffecf13ab7d4a9e","width":140,"height":140,"tag":"140x140"}]},"relatedTickers":["GILD"]},"179d69e6-8b66-3e95-bd2b-d91797c09c2f":{"uuid":"179d69e6-8b66-3e95-bd2b-d91797c09c2f","title":"Investigational Lenacapavir Receives Positive CHMP Opinion for People With Multi-Drug Resistant HIV","publisher":"Business Wire","link":"https://finance.yahoo.com/news/investigational-lenacapavir-receives-positive-chmp-120000547.html","providerPublishTime":1656072000,"type":"STORY","thumbnail":{"resolutions":[{"url":"https://s.yimg.com/uu/api/res/1.2/jQziLqBO5_WIEjt1LZ328A--~B/aD0xNjA7dz00ODA7YXBwaWQ9eXRhY2h5b24-/https://s.yimg.com/uu/api/res/1.2/113l.fAtIV2j57zFLybimQ--~B/aD0xNjA7dz00ODA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/bc5dc56130d0998fc174ccc09f44e851","width":480,"height":160,"tag":"original"},{"url":"https://s.yimg.com/uu/api/res/1.2/yH8xue7MNkenMlllzYyXhA--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://s.yimg.com/uu/api/res/1.2/113l.fAtIV2j57zFLybimQ--~B/aD0xNjA7dz00ODA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/bc5dc56130d0998fc174ccc09f44e851","width":140,"height":140,"tag":"140x140"}]},"relatedTickers":["GILD"]},"3d1b2931-c53f-341c-bfb6-bbffc5d75939":{"uuid":"3d1b2931-c53f-341c-bfb6-bbffc5d75939","title":"2 Beaten-Down Dividend Stocks That Are Now Yielding 5%","publisher":"Motley Fool","link":"https://finance.yahoo.com/m/3d1b2931-c53f-341c-bfb6-bbffc5d75939/2-beaten-down-dividend-stocks.html","providerPublishTime":1655996400,"type":"STORY","thumbnail":{"resolutions":[{"url":"https://s.yimg.com/uu/api/res/1.2/ClRvEfUaFizzGBstMtT5Ww--~B/aD03NTI7dz0xNDAwO2FwcGlkPXl0YWNoeW9u/https://s.yimg.com/uu/api/res/1.2/U4dNgHuXDPgVLj9kBWWTKg--~B/aD03NTI7dz0xNDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/motleyfool.com/4d6d9b2b503f9895aeed00e408f41bce","width":1400,"height":752,"tag":"original"},{"url":"https://s.yimg.com/uu/api/res/1.2/8IfB_nzYpzlpYwq9Yyoq5Q--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://s.yimg.com/uu/api/res/1.2/U4dNgHuXDPgVLj9kBWWTKg--~B/aD03NTI7dz0xNDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/motleyfool.com/4d6d9b2b503f9895aeed00e408f41bce","width":140,"height":140,"tag":"140x140"}]},"relatedTickers":["GILD","BBY","^GSPC"]},"402231f9-1480-3de2-a8c5-42b01dd5a413":{"uuid":"402231f9-1480-3de2-a8c5-42b01dd5a413","title":"Treatment With Hepcludex\xae (Bulevirtide) Meets Primary Endpoint and Achieves Significant Response in Chronic Hepatitis Delta Virus at 48 Weeks","publisher":"Business Wire","link":"https://finance.yahoo.com/news/treatment-hepcludex-bulevirtide-meets-primary-123000615.html","providerPublishTime":1655987400,"type":"STORY","thumbnail":{"resolutions":[{"url":"https://s.yimg.com/uu/api/res/1.2/iaAu6jmAPeK9wKNqReLWfg--~B/aD0xNjA7dz00ODA7YXBwaWQ9eXRhY2h5b24-/https://s.yimg.com/uu/api/res/1.2/VE2SIZLf.uawHEEJ0f.Ikw--~B/aD0xNjA7dz00ODA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/cfe2b1e0587c74bcdd994c1f33d6da3c","width":480,"height":160,"tag":"original"},{"url":"https://s.yimg.com/uu/api/res/1.2/5vhPc4Krodb8MpGNB3.UlQ--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://s.yimg.com/uu/api/res/1.2/VE2SIZLf.uawHEEJ0f.Ikw--~B/aD0xNjA7dz00ODA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/cfe2b1e0587c74bcdd994c1f33d6da3c","width":140,"height":140,"tag":"140x140"}]},"relatedTickers":["GILD"]},"b2f7a317-9b46-36f6-9277-7b99f65d9306":{"uuid":"b2f7a317-9b46-36f6-9277-7b99f65d9306","title":"Gilead Sciences (GILD) Gains As Market Dips: What You Should Know","publisher":"Zacks","link":"https://finance.yahoo.com/news/gilead-sciences-gild-gains-market-215009514.html","providerPublishTime":1655934609,"type":"STORY","thumbnail":{"resolutions":[{"url":"https://s.yimg.com/uu/api/res/1.2/P9MYT7bkg6gW.LAUks5bQg--~B/aD02NzU7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://s.yimg.com/uu/api/res/1.2/5w_iAw5naBqMPrzpIECi9Q--~B/aD02NzU7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/670d1917693293f70179651625deb88f","width":900,"height":675,"tag":"original"},{"url":"https://s.yimg.com/uu/api/res/1.2/G6Kfmbo.AIHKSvpKRICHXQ--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://s.yimg.com/uu/api/res/1.2/5w_iAw5naBqMPrzpIECi9Q--~B/aD02NzU7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/670d1917693293f70179651625deb88f","width":140,"height":140,"tag":"140x140"}]},"relatedTickers":["GILD"]},"c38b069a-f2a2-35a2-a361-2be027eb6fa9":{"uuid":"c38b069a-f2a2-35a2-a361-2be027eb6fa9","title":"Ex-girlfriend of biotech CFO pleads guilty to insider trading","publisher":"Reuters","link":"https://finance.yahoo.com/news/ex-girlfriend-biotech-cfo-pleads-174128451.html","providerPublishTime":1655919688,"type":"STORY","relatedTickers":["GILD"]},"e9900225-e2c3-39f3-bc85-33e63e80e404":{"uuid":"e9900225-e2c3-39f3-bc85-33e63e80e404","title":"Providing Health and Wellness Support for Women in Chicago with Breast Cancer","publisher":"News Direct","link":"https://finance.yahoo.com/news/providing-health-wellness-support-women-132507144.html","providerPublishTime":1655904307,"type":"STORY","thumbnail":{"resolutions":[{"url":"https://s.yimg.com/uu/api/res/1.2/.wvtWm4HkDBp8mOFWBJzVA--~B/aD0zNjY7dz02NTA7YXBwaWQ9eXRhY2h5b24-/https://s.yimg.com/uu/api/res/1.2/5HE2BQjuWKZenR.IY5ibOg--~B/aD0zNjY7dz02NTA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/news_direct/78900ae538842ab0010eaf725f8e599a","width":650,"height":366,"tag":"original"},{"url":"https://s.yimg.com/uu/api/res/1.2/Y.xeuL_UhgPIV_xXSuQcFg--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://s.yimg.com/uu/api/res/1.2/5HE2BQjuWKZenR.IY5ibOg--~B/aD0zNjY7dz02NTA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/news_direct/78900ae538842ab0010eaf725f8e599a","width":140,"height":140,"tag":"140x140"}]},"relatedTickers":["GILD"]},"b0266de7-01a4-3663-a42c-a519cbb976e0":{"uuid":"b0266de7-01a4-3663-a42c-a519cbb976e0","title":"Gilead to Present Latest Data From Across Liver Disease Development Programs at the International Liver Congress\u2122 2022","publisher":"Business Wire","link":"https://finance.yahoo.com/news/gilead-present-latest-data-across-130000476.html","providerPublishTime":1655816400,"type":"STORY","thumbnail":{"resolutions":[{"url":"https://s.yimg.com/uu/api/res/1.2/rHQpYPIIKbosDwY6x6nw7A--~B/aD0xNjA7dz00ODA7YXBwaWQ9eXRhY2h5b24-/https://s.yimg.com/uu/api/res/1.2/IqT34mtDWRo_221fMnSDUQ--~B/aD0xNjA7dz00ODA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/b90e7c8d7d963d5840eb5bbafb5e43af","width":480,"height":160,"tag":"original"},{"url":"https://s.yimg.com/uu/api/res/1.2/RDbDeX8jHLvNF_SFmeU3wQ--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://s.yimg.com/uu/api/res/1.2/IqT34mtDWRo_221fMnSDUQ--~B/aD0xNjA7dz00ODA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/b90e7c8d7d963d5840eb5bbafb5e43af","width":140,"height":140,"tag":"140x140"}]},"relatedTickers":["GILD"]}}')}}]);